Karyopharm Therapeutics | KPTI - Stock

Aktienkurs
8.00
Täglich Wechseln
-0.16 -1.96%
Monatlich
-8.57%
Jährlich
86.48%
Q2 Prognose
7.78




Stock Veränderung Datum
AbbVie USD 4.95B 13M 2025-12
Abbott USD 6.49B 220M 2025-12
Amgen USD 6.22B 121M 2025-12
AstraZeneca USD 6.59B 126M 2025-09
BioCryst Pharmaceuticals USD 5.4M 166K 2025-12
Bristol-Myers Squibb USD 2.76B 21M 2025-09
Eli Lilly USD 13.74B 1.56B 2025-12
GlaxoSmithKline GBP 6.12B 46M 2025-09
Incyte USD 101.06M 17.61M 2025-12
J&J USD 14.19B 45M 2025-12
Karyopharm Therapeutics USD 4.04M 72K 2025-12
MacroGenics USD 7.91M 840K 2025-12
Merck USD 6.44B 157M 2025-09
Nektar Therapeutics USD 14.46M 1.78M 2024-06
Novartis USD 6.42B 114M 2025-09
Novartis USD 6.42B 114M 2025-09
Pfizer USD 11.47B 201M 2025-09
Regeneron Pharmaceuticals USD 3.2B 53.6M 2025-12
Roche Holding CHF 7.6B 9M 2025-06
Takeda JPY 1.41T 107.71B 2025-12
TG Therapeutics USD 125.59M 21.37M 2025-12
Ultragenyx Pharmaceutical USD 52.2M 5.7M 2025-09